Aug 10 2010
Companiesandmarkets.com, an online compiler of business information, provides report on a novel market research for Continuous Glucose Monitoring in the European markets.
It has reported that analysts at Frost & Sullivan explored France Benelux, Italy Germany, Spain, Scandinavia, and the United Kingdom for studying the components favoring the growth of market and tracing the opportunities and problems associated within the markets. The high levels of occurrence of diabetes, stroke and cardiovascular diseases among the older population in the region of Western Europe emphasized the necessity of periodic examination of glucose levels in the patients.
The CGM devices are convenient and beneficial compared to the conventional glucose monitoring methods. But the expensive disposable sensor and the non- reimbursement of CGM device restricts the patients from using it. In order to overcome this challenge and to achieve appropriate diabetic therapy management, the development of a suitable, user-friendly, cost-effective CGM device to monitor glucose levels is imminent. Manufacturers, with the assistance of distinguished local companies, can offer better cost-effective services by the inclusion of insulin pumps to CGM, which will make the device reimbursable and economical.
Source: http://www.companiesandmarkets.com